Search
for
Sort by
Research 30 of 291
- Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective
- Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome
- Treatment of alopecia X with medroxyprogesterone acetate
- Medroxyprogesterone acetate therapy in hirsutism
- Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
- Treatment of idiopathic facial hirsutism with medroxyprogesterone acetate iontophoresis
- PROGRESSIVE SLEEP APNOEAS RESPOND TO MEDROXYPROGESTERONE ACETATE
- The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial
- Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- PHARMACOVIGILANCE STUDY OF SIDE EFFECTS ASSOCIATED WITH LEVONORGESTROL -ETHINYL ESTRADIOL AND DEPOTMEDROXY PROGESTERONE ACETATE
- Side effects of androgen deprivation therapy: monitoring and minimizing toxicity
- Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy
- Progestogens in menopausal hormone therapy
- Polycystic Ovary Syndrome
- Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury
- Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
- Assessing medication use patterns among patients with polycystic ovary syndrome at a tertiary care teaching hospital in South Korea: A retrospective study
- Sindrom policističnih jajnika - izazovi i mogućnosti liječenja
- Polycystic ovary syndrome - challenges and opportunities
- АЛОПЕЦИЯ Х. Продолжение. Начало в №5(27)-2015
- The Effects of Estradiol, Androgens and the Selective Estrogen Modulators: Ospemifene, Raloxifene and Tamoxifen on Explant Cultures of Human Breast Tissue
- Sex hormones and related compounds, including hormonal contraceptives
- Basics of Hormonal Contraception
- A Review of Androgen‐Progestin Regimens for Male Contraception
- Management of Clinical Side Effects of DMPA
- THE PEDIATRICIAN AND THE SEXUALLY ACTIVE ADOLESCENT
- A systematic review of antiandrogens and feminization in transgender women
- Depo-Provera: an injectable contraceptive.
- Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells